- The stock price of Medifast (MED) fell by over 15% during intraday trading today. This is why.
The stock price of Medifast (MED) fell by over 15% during intraday trading today. Investors are responding to the company’s second-quarter results.
Medifast reported a Q2 EPS of $3.87, which was $0.64 higher than analyst estimates of $3.23. And the revenue for the quarter was $453.3 million compared to the consensus estimate of $447.87 million.
Going forward, Medifast expects an FY2022 EPS of between $12.70 and $14.10, compared to the consensus of $15.38. And Medifast expects FY2022 revenue of between $1.58 and $1.66 billion, compared to the consensus of $1.8 billion.